The Pre-Conference Workshop, as part of the Clinical Trial Summit of Pakistan (CTSP) 2025, was organized by Aga Khan University (AKU) and National University of Medical Sciences (NUMS) in collaboration with Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore and Shaikh Zayed Postgraduate Medical Institute, Lahore. The event was supported by the Association of Clinical Research Professionals (ACRP), Drug Regulatory Authority of Pakistan (DRAP), and the Association of Physicians of Pakistani Descent in North America (APPNA).
The workshop was designed for researchers, clinicians, healthcare professionals, and postgraduate students with an interest in clinical trials. Participation was limited to 25 slots.
A brief introduction to the workshop, outlining its objectives and importance in the field of clinical trials.
A pre-test was conducted to assess the baseline knowledge of participants about clinical trials.
Speaker: Dr. Farah Asif
Topics Covered:
Speaker: Dr. Ayesha Humayun
Topics Covered:
Speaker: Dr. Ayesha Humayun
Topics Covered:
Speaker: Dr. Baber Saeed Khan
Topics Covered:
A post-test was conducted to evaluate participants' learning, followed by feedback collection and certificate distribution.
The Pre-Conference Workshop on Clinical Trials provided a comprehensive understanding of clinical trial design, execution, monitoring, and ethical considerations. Participants gained valuable hands-on experience in protocol writing, sample size calculation, and trial management. The discussions on regulatory compliance and ethical frameworks ensured that attendees are well-prepared for conducting high-quality research. The interactive sessions, including group discussions and post-workshop evaluations, reinforced the key concepts essential for conducting clinical trials in compliance with international standards.
The workshop served as a significant stepping stone for researchers and healthcare professionals, equipping them with the necessary skills and knowledge to design, execute, and report clinical trials effectively.